TrialTrials2019

Development of the IRIS-AR strategy: an intervention to improve rates of accrual and retention for the VTE-PRO randomized controlled trial.

Christine Fahim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.